Skip to content

Clinical trials

Phase 1/2 Waldenstrom Macroglobulinemia trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 1/2 Status: Unknown status Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centaurus Biopharma Co., Ltd.1
LifeTime Pharmaceuticals1
National University Hospital, Singapore1
Technical University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia4
Lymphoma2
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Follicular1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Mantle-Cell1
Neoplasms1
Recurrence1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.